MIPS521

MIPS521 is a modulator of Adenosine Receptors used in studies of GPCR Signaling. It is especially relevant in cardiovascular and inflammation models, where defined compound exposure can be linked to receptor-driven second-messenger signaling and desensitization dynamics.

By modulating Adenosine Receptors, MIPS521 can be used to examine receptor-driven second-messenger signaling and desensitization dynamics. The gpcr annotation adds relevance to GPCR pharmacology, ligand-binding, and signaling assays, together with downstream-response mapping in the same experimental setting. In cardiovascular and inflammation models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Adenosine Receptors
• Pathway perturbation studies connected to GPCR Signaling
• Context-dependent response profiling and mechanism comparison
• GPCR pharmacology, ligand-binding, and signaling assays

Overall, MIPS521 is appropriate when a defined chemical perturbant is needed to connect Adenosine Receptors with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cardiovascular and inflammation models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.